Drug LitigationXarelto Advertisements Failed to Disclose the Reality of Risks, Lawsuit Alleges

October 23, 2015
Many Xarelto lawsuits that have been filed against Johnson & Johnson and Bayer Corporation allege that the pharmaceutical companies failed to disclose the reality of the blood thinner’s risks and dangers. Xarelto has been prescribed as a blood thinner to treat many conditions, from nonvalvular atrial fibrillation, deep vein thrombosis, to pulmonary embolism. The favorable studies that center on the drug’s positive outcomes are also at question, due to the many cases of uncontrolled bleeding that sometimes lead to death in Xarelto patients nationwide. Other patients have suffered strokes, retinal hemorrhages, epidural hematoma, intracranial hemorrhages, hemoglobin decrease, gastrointestinal hemorrhages, and adrenal bleeding.
Legal Commentary
Nachawati Law Group’s Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time.

About Nachawati Law Group

Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact help@ntrial.com or call 214-890-0711.